Literature DB >> 26872906

Linezolid-induced optic neuropathy with a rare pathological change in the inner retina.

Nobuhito Ishii1, Reiko Kinouchi2,3, Masatomo Inoue4, Akitoshi Yoshida1.   

Abstract

We report a case of linezolid-induced optic neuropathy with transient microcystic spaces in the inner retina. We observed the retina using Fourier-domain optical coherence tomography (FD-OCT) in a patient with linezolid-induced optic neuropathy. A 49-year-old woman presented to our department with a 1-week history of bilateral photophobia. At the first visit, her best-corrected visual acuity (VA) was 0.6 in the right eye and 0.5 in the left eye. She had moderate optic disk edema and central scotomas bilaterally. FD-OCT showed bilateral microcystic spaces in the retina. Microcystic spaces were seen in the retinal nerve fiber layer (RNFL) and at the border of the RNFL and the retinal ganglion cell layer. Magnetic resonance imaging and laboratory tests showed no positive findings except for an elevated lactic acid level. One week after the first visit, the VA levels decreased to 0.06 and 0.07 in the right and left eyes, respectively. Because the patient had a 7-month history of linezolid treatment for persistent pyogenic arthritis, we suspected linezolid-induced optic neuropathy and immediately terminated treatment with this drug. The optic disk edema and the microcystic spaces in the retina resolved, and the VA improved to 1.2 at 6 weeks after linezolid withdrawal. Microcystic spaces, which resolved with linezolid withdrawal, were observed in linezolid-induced optic neuropathy. The microcystic spaces in the inner retina can be the first retinal sign of some optic neuropathies.

Entities:  

Keywords:  Ganglion cell complex; Linezolid; Microcystic spaces; Retinal nerve fiber layer

Mesh:

Substances:

Year:  2016        PMID: 26872906     DOI: 10.1007/s10792-016-0196-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  12 in total

Review 1.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

2.  Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface.

Authors:  Brandon J Lujan; Jonathan C Horton
Journal:  Brain       Date:  2013-07-19       Impact factor: 13.501

Review 3.  Linezolid-induced optic neuropathy: a mitochondrial disorder?

Authors:  M Javaheri; R N Khurana; T M O'hearn; M M Lai; A A Sadun
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

4.  Microcystic macular oedema confirmed, but not specific for multiple sclerosis.

Authors:  Lisanne J Balk; Joep Killestein; Chris H Polman; Bernard M J Uitdehaag; Axel Petzold
Journal:  Brain       Date:  2012-10-17       Impact factor: 13.501

5.  Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration.

Authors:  Piero Barboni; Valerio Carelli; Giacomo Savini; Michele Carbonelli; Chiara La Morgia; Alfredo A Sadun
Journal:  Brain       Date:  2013-02-08       Impact factor: 13.501

6.  Linezolid-associated toxic optic neuropathy.

Authors:  J C Rucker; S R Hamilton; D Bardenstein; C M Isada; M S Lee
Journal:  Neurology       Date:  2006-02-28       Impact factor: 9.910

7.  Linezolid-induced inhibition of mitochondrial protein synthesis.

Authors:  An S De Vriese; Rudy Van Coster; Joel Smet; Sara Seneca; Andrew Lovering; Lindsey L Van Haute; Ludo J Vanopdenbosch; Jean-Jacques Martin; Chantal Ceuterick-de Groote; Stefaan Vandecasteele; Johan R Boelaert
Journal:  Clin Infect Dis       Date:  2006-03-13       Impact factor: 9.079

Review 8.  Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.

Authors:  Matthew S Dryden
Journal:  J Antimicrob Chemother       Date:  2011-05       Impact factor: 5.790

9.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.

Authors:  Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi
Journal:  Lancet Neurol       Date:  2012-10-04       Impact factor: 44.182

Review 10.  Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies.

Authors:  Valerio Carelli; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

View more
  3 in total

Review 1.  Linezolid: a review of its properties, function, and use in critical care.

Authors:  Seyed Mohammad Reza Hashemian; Tayebeh Farhadi; Mojdeh Ganjparvar
Journal:  Drug Des Devel Ther       Date:  2018-06-18       Impact factor: 4.319

2.  Linezolid-Induced Toxic Optic Neuropathy.

Authors:  Meshaal A Aljebreen; Abdulaziz K Alotaibi; Malek Alrobaian
Journal:  Middle East Afr J Ophthalmol       Date:  2021-01-19

3.  Linezolid-Induced Pure Red Cell Aplasia: A Case Report.

Authors:  Xiao-Yan Yang; Lin Chen; Ji-Na Gu; Cheng-Jun Zeng; Dan-Mei Pan
Journal:  Infect Drug Resist       Date:  2022-07-20       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.